Nuclear Medicine ExplainedNM Explained
LearnAnimationsBoard ReviewToolsCalendar
Review
TREN

Settings and progress transfer · Help · About · AI and Claude · Legal

For educational purposes only; not a clinical decision tool.

Solve questions (25)

Contents

  1. 27.1 Gamma Camera Quality Control (Daily, Weekly, Annual)
  2. 27.2 PET/CT Quality Control
  3. 27.3 Dose Calibrator Quality Control
  4. 27.4 Radiopharmaceutical Quality Control (TLC, Purity Tests)
  5. 27.5 Licensing and Regulation (TAEK, IAEA, NRC)
  6. 27.6 Radioactive Waste Management
  7. Key Points for the Board
  8. Current guidelines on this chapter's topics
← Back‹ Chapter 26Chapter 28 ›

Chapter 27Quality, innovations and statisticsLast reviewed: 14 Nov 2026 · What's new

Quality Control and Regulation

This chapter's English text is a draft translation (prepared with Claude and checked against a terminology glossary and automatic checks); specialist review is in progress. Please report errors with the feedback button.

Solve questions (25) →
Contents
  1. 27.1 Gamma Camera Quality Control (Daily, Weekly, Annual)
  2. 27.2 PET/CT Quality Control
  3. 27.3 Dose Calibrator Quality Control
  4. 27.4 Radiopharmaceutical Quality Control (TLC, Purity Tests)
  5. 27.5 Licensing and Regulation (TAEK, IAEA, NRC)
  6. 27.6 Radioactive Waste Management
  7. Key Points for the Board
  8. Current guidelines on this chapter's topics
Learning objectives and modules3 modules · about 2 h 35 min

Learning objectives

After this chapter you will be able to:

  • List gamma camera quality control tests with their frequencies and acceptance limits.
  • Explain PET/CT quality control tests.
  • Apply dose calibrator tests (constancy, linearity, accuracy, geometry).
  • Apply radiopharmaceutical quality control (radiochemical purity, Mo-99 breakthrough, aluminium) and interpret the result.
  • State the basic rules of licensing, transport and radioactive waste management.

Modules

The chapter is divided into study modules without changing the order of the text: read, watch the animations, then answer the questions linked to those headings.

  1. Module 127.1–27.2 Gamma Camera Quality Control (Daily, Weekly, Annual) · PET/CT Quality Control1 h · 5 animations · 19 questionsAnswer the questions →
  2. Module 227.3–27.4 Dose Calibrator Quality Control · Radiopharmaceutical Quality Control (TLC, Purity Tests)50 min · 1 animation · 24 questionsAnswer the questions →
  3. Module 327.5–27.6 Licensing and Regulation (TAEK, IAEA, NRC) · Radioactive Waste Management · Key Points for the Board45 min · 2 animations · 13 questionsAnswer the questions →

Times are estimates: 130 words per minute, 3 min per animation, 1.5 min per question.

Tip cards (46) →

MOST FREQUENTLY ASKED IN THIS CHAPTER

✓
First daily test: energy peak check (peaking) → if the photopeak is wrong, everything is affected
✓
Daily uniformity: intrinsic = without collimator + point source (5 × FOV); extrinsic = with collimator + flood source
✓
Uniformity formula: IU = (Max − Min) / (Max + Min) × 100%
✓
Acceptable integral uniformity: ≤3-5% (intrinsic), ≤5% (extrinsic)
✓
Minimum counts: 3-5 million (daily), >30-100 million (annual high-count)
✓
Weekly: spatial resolution and linearity with a bar phantom
✓
COR test: every 3-6 months, acceptable error ≤0.5 pixel

27.1 Gamma Camera Quality Control (Daily, Weekly, Annual)16 questions

General Principles

•
Quality control (QC) → ensures the gamma camera produces accurate, reliable and reproducible images
•
QC tests are classified by frequency: daily, weekly, annual (or acceptance test)
•
All QC results must be recorded and compared with reference values
•
Acceptance test: when the device is first installed → reference values are established
•
All subsequent tests are compared with these reference values

EANM Concepts:

•
Constancy tests: check whether there has been any change relative to reference data; performed by the staff using the device
•
Acceptance tests: verify compliance with technical, legal and manufacturer specifications; performed by the manufacturer
•
If the action level is exceeded, an investigation is started within the quality management framework
•
If the tolerance limit is exceeded, clinical use of the device may be restricted or stopped; causes and consequences are documented
•
Each quality control procedure is recorded with the date and the initials of the person performing it; trends moving towards the action level should be addressed early

Daily Quality Control Tests

1. Energy Peak Check (Peaking / Photopeak Check):

•
Aim: to verify that the photopeak centre is in the correct position
•
Method: with a point source of Tc-99m (140 keV) or of the radionuclide to be used
•
Energy window: usually ±10% or ±15% (depending on the radionuclide)
•
Photopeak shift → energy resolution deteriorates, image quality falls
•
Must be performed every day before patient studies
•
PMT gain drift → the most common cause of photopeak shift
BOARD TIP
▸
"First test to be performed daily on a gamma camera?"

→ Energy peak check (peaking). If the photopeak is wrong, all other tests and patient images are affected → it must be done before anything else!

Left: the ±10% window on the energy spectrum and a Tc-99m photopeak sliding with gain drift; a flood image building up as counts accumulate (normal or with a PMT failure); a four-quadrant bar phantom. Right: the share of counts in the window, UFOV and CFOV integral uniformity, and which quadrant is resolved.

Continuous stream · no seeking

Daily energy peak and uniformity checks and the weekly bar phantom ensure the camera gives accurate, uniform and linear images.

Source: test methods and acceptance values from the book (27.1, EANM); uniformity calculated as in NEMA NU 1. Camera size, PMT failure magnitude and counts representative.

How to use: a single click on the drawing pauses and resumes; in the uniformity and bar phantom figures ↑ ↓ or the buttons below switch the state (normal / fault); use the time bar below to go to any moment.

Speed
Test yourself:Chapter 27 · question 1
Did this animation help you understand the topic?

Figure 27.1: Energy peak check: a correctly set Tc-99m photopeak with a ±10% window, and photopeak shift due to PMT gain drift (schematic).

2. Daily Uniformity Test (Flood Field Uniformity):

•
Aim: to verify a homogeneous response across the detector surface
•
Intrinsic uniformity: without a collimator, point source (Tc-99m, ~100-500 µCi) at 5 × FOV from the detector
•
Extrinsic (system) uniformity: collimator mounted, planar source (flood phantom, Co-57 sheet source or Tc-99m-filled flood phantom)
–
Advantages of a Co-57 sheet source over a liquid phantom filled with Tc-99m: no preparation needed, constant thickness, no air bubble or poor-mixing artefacts, lower staff dose
•
Minimum counts: 3-5 million (planar), >10,000 counts/cm²
•
Assessment parameters:
•
Integral uniformity: maximum-minimum difference over the whole FOV

IU (%) = (Max − Min) / (Max + Min) × 100

•
Differential uniformity: maximum difference between neighbouring pixels (same formula, over a 5-pixel region)
•
Acceptable values:
•
Intrinsic integral uniformity: ≤3-5% (UFOV), ≤3% (CFOV)
•
Extrinsic integral uniformity: ≤5% (UFOV)
•
Causes of non-uniformity: PMT failure, crystal damage, collimator damage, energy window shift
BOARD TIP
▸
"Difference between intrinsic and extrinsic uniformity?"

→ Intrinsic = without collimator (point source), extrinsic = with collimator (flood source).

▸
"Minimum counts in the uniformity test?"

→ 3-5 million.

▸
"What does a ring artefact indicate in SPECT?"

→ Non-uniformity → PMT failure or crystal defect.

Left: the ±10% window on the energy spectrum and a Tc-99m photopeak sliding with gain drift; a flood image building up as counts accumulate (normal or with a PMT failure); a four-quadrant bar phantom. Right: the share of counts in the window, UFOV and CFOV integral uniformity, and which quadrant is resolved.

Continuous stream · no seeking

Daily energy peak and uniformity checks and the weekly bar phantom ensure the camera gives accurate, uniform and linear images.

Source: test methods and acceptance values from the book (27.1, EANM); uniformity calculated as in NEMA NU 1. Camera size, PMT failure magnitude and counts representative.

How to use: a single click on the drawing pauses and resumes; in the uniformity and bar phantom figures ↑ ↓ or the buttons below switch the state (normal / fault); use the time bar below to go to any moment.

Speed
Test yourself:Chapter 27 · question 2Chapter 27 · question 3
Did this animation help you understand the topic?

Figure 27.2: Set-up for intrinsic and extrinsic uniformity tests, flood image with a PMT failure and the integral uniformity formula (schematic).

3. Daily Background Check:

•
Aim: to verify the absence of ambient radiation and contamination
•
A short count is acquired without a source
•
High background → contamination or a radioactive source nearby
•
EANM: the background check also looks for excessive electronic noise
•
Additional daily checks according to EANM: visual and physical inspection, touch-sensitive (collision) surface test (also after every collimator change), emergency stop buttons
•
EANM: extrinsic uniformity can be checked daily with Tc-99m, Co-57 or Gd-153

Weekly Quality Control Tests

1. Spatial Resolution and Linearity:

•
Aim: to assess the spatial resolution and geometric linearity of the detector
•
Method: a bar phantom (parallel-line phantom) or orthogonal hole phantom is used
•
Bar phantom: 4 quadrants, different line spacings (e.g. 2.0, 2.5, 3.0, 3.5 mm)
•
Visual assessment: lines should be straight, parallel and sharp
•
Non-linearity: curving or bending of the lines → PMT or electronic problem
•
Can be done intrinsically (without collimator) or extrinsically (with collimator)

Left: the ±10% window on the energy spectrum and a Tc-99m photopeak sliding with gain drift; a flood image building up as counts accumulate (normal or with a PMT failure); a four-quadrant bar phantom. Right: the share of counts in the window, UFOV and CFOV integral uniformity, and which quadrant is resolved.

Continuous stream · no seeking

Daily energy peak and uniformity checks and the weekly bar phantom ensure the camera gives accurate, uniform and linear images.

Source: test methods and acceptance values from the book (27.1, EANM); uniformity calculated as in NEMA NU 1. Camera size, PMT failure magnitude and counts representative.

How to use: a single click on the drawing pauses and resumes; in the uniformity and bar phantom figures ↑ ↓ or the buttons below switch the state (normal / fault); use the time bar below to go to any moment.

Speed
Did this animation help you understand the topic?

Figure 27.3: Four-quadrant bar phantom image: normal appearance and non-linearity due to a PMT/electronic problem (schematic).

2. Measurement of Spatial Resolution:

•
Quantitative measurement: FWHM (Full Width at Half Maximum) → line spread function (LSF)
•
Intrinsic spatial resolution: typically 3-4 mm (modern cameras)
•
System (extrinsic) resolution: collimator-dependent → 8-12 mm (with a LEHR collimator)

Annual (or Semi-Annual) Quality Control Tests

1. Centre of Rotation (COR):

•
A critical SPECT-specific test
•
Aim: to verify alignment between the mechanical centre of rotation of the detector and the electronic centre
•
Method: point source (Tc-99m), 360° rotation, sinogram analysis
•
COR error → doubling or blurring artefact on SPECT images
•
Acceptable COR error: ≤0.5 pixel (usually ≤3.2 mm)
•
Should be done every 3-6 months or after a collimator change
BOARD TIP
▸
"Most common cause of a doubling artefact in SPECT?"

→ COR error.

▸
"How often is the COR test performed?"

→ Every 3-6 months or after a collimator change.

▸
"Acceptable COR error?"

→ ≤0.5 pixel.

Three SPECT artefacts are shown with real projection and filtered back-projection: a sinogram break and double contour with patient motion halfway through acquisition, a sinogram stripe and a ring in the slice with detector non-uniformity, and blurring of a point source that turns into a ring with a centre-of-rotation (COR) error. The size of the error is chosen in each step.

Continuous stream · no seeking

Key point: SPECT assumes all projections are consistent; patient motion gives a break and double contour, a fixed detector defect a ring, and a centre-of-rotation shift a blurred or ring-shaped point source.

Source: book (sinogram break, double contour/streaks; non-uniformity → ring; COR: blurred if small, doughnut if large; COR test every 3-6 months). Calculation: same projector as the tomography animation, 64 × 64 (4 mm pixels), 96 angles / 360°, ramp-filtered FBP with 3 × 3 smoothing, noise-free. Shift, defect and COR values illustrative.

How to use: ↑ ↓ or the buttons below change the size of the fault (shift, sensitivity loss, centre-of-rotation error); the sinogram and the slice are recomputed for each choice; ← → change steps.

Speed
Test yourself:Chapter 27 · question 4
Did this animation help you understand the topic?

Figure 27.4: Centre of rotation (COR) error: mismatch between mechanical and electronic centres, shift in the sinogram and ring/blurring artefact on reconstruction (schematic).

2. Uniformity (High-Count):

•
Unlike daily uniformity, high-count (>30-100 million counts)
•
More sensitive uniformity assessment → detection of small defects
•
Uniformity is critical in SPECT reconstruction → even a 1% uniformity error can cause a ring artefact
•
A non-uniformity of ~1% in a planar image can grow to ~20% in SPECT reconstruction (ring or bull's-eye artefact); for the correction map ~30 million counts are recommended in a 64×64 matrix and ~120 million in a 128×128 matrix

3. Energy Resolution:

•
Photopeak width is measured → FWHM / photopeak energy × 100%
•
Typical energy resolution for NaI(Tl): 9-10% (at 140 keV)
•
Deterioration of energy resolution → crystal ageing, PMT deterioration, moisture ingress
•
Multiple window spatial registration (MWSR): tests whether images acquired in different energy windows (e.g. the 93, 185 and 300 keV windows of Ga-67, In-111) superimpose at the same position and size; when faulty, size and position differences arise between windows and the image is blurred

4. Count Rate Performance:

•
To assess the dead-time loss of the detector at high activity
•
Two-source method or decaying-source method
•
Dead time: paralysable or non-paralysable model
•
Acceptable loss: 20% (at clinical count rates)

5. Spatial Resolution (Quantitative):

•
FWHM and FWTM measurement → with a line source or point source
•
Compared annually with reference values

6. Sensitivity:

•
Count rate per unit activity (cps/MBq or cps/µCi)
•
Measured with a planar source of known activity
•
Depends on collimator type → LEHR < LEGP < LEHS (order of sensitivity)

7. SPECT Performance – Jaszczak Phantom (EANM):

•
The uniform section shows ring artefacts; spheres and rods of different diameters show contrast and resolution
•
The phantom is filled with ~300 MBq Tc-99m and a high-count SPECT lasting ~15-30 minutes is acquired

SPECT/CT-Specific Quality Control

CT Component:

•
Daily: CT number accuracy (water phantom → HU = 0 ± 5)
•
Weekly/Monthly: CT uniformity, noise
•
Annual: CT dose index (CTDI), spatial resolution, low-contrast resolution

SPECT-CT Co-registration:

•
Spatial alignment of SPECT and CT images is checked
•
Misregistration → attenuation correction errors → incorrect localisation
•
Acceptable error: ≤1 pixel (usually ≤5 mm)
•
Tested with a line source or point source phantom

CT Daily QC (EANM):

•
Tube warm-up, automatic function checks, air and water calibration at all voltages; laser alignment is checked at the start of the day
•
In the water phantom the difference between the CT numbers of 5 regions of interest should not exceed 2 SD; a ring artefact indicates deviation from a homogeneous response
•
For CT used only for attenuation correction these requirements may be relaxed
BOARD TIP
▸
"Most common cause of attenuation correction artefact in SPECT/CT?"

→ SPECT-CT misregistration.

▸
"What should the CT HU value be for water?"

→ 0 ± 5 HU.

▸
"A ring artefact in SPECT indicates failure of which QC test?"

→ Uniformity.

27.2 PET/CT Quality Control3 questions

Daily Quality Control

1. Detector Normalisation / Blank Scan:

•
Aim: to verify that all detector blocks respond homogeneously
•
Method: with a Ge-68 rod source or cylindrical phantom
•
Sinogram analysis → faulty detector blocks are identified
•
Faulty block → streak artefact on the sinogram

2. Timing Calibration:

•
Accuracy of the coincidence timing window
•
Especially critical in TOF-PET → timing error → localisation error

3. Daily QC Phantom:

•
Phantom supplied by the manufacturer (usually a Ge-68 cylinder)
•
Check of SUV accuracy, uniformity, calibration factor
•
EANM: daily quality control is performed with a uniformly filled Ge-68/Ga-68 phantom; in digital PET the intrinsic activity of Lu-176 in the LSO crystal can also be used (not available from every manufacturer)
•
EANM: PET/CT alignment is checked every 6 months; the permitted deviation in SPECT/CT alignment is ≤5 mm
•
EARL programme: harmonises quality control between centres and allows quantitative results (SUV) to be compared

Weekly/Monthly Quality Control

1. Uniformity:

•
With a cylindrical phantom (filled with Ge-68 or F-18)
•
Axial and transaxial uniformity are assessed
•
Acceptable: ≤5% variation

2. SUV Accuracy (Calibration Verification):

•
Phantom of known activity → measured SUV compared with the expected value
•
Acceptable error: ±10%
•
Cross-calibration: agreement between the PET camera and the dose calibrator

Annual (or Acceptance Test) Quality Control

1. Spatial Resolution:

•
With an F-18 point or line source
•
FWHM measurement → typical PET resolution: 4-6 mm
•
Measured separately at the centre and periphery (worse at the periphery → parallax error)

2. Sensitivity:

•
NEMA NU 2 protocol → aluminium-sleeved line source
•
Measured in cps/kBq

3. Scatter Fraction:

•
With the NEMA NU 2 phantom
•
Scatter fraction: typically 25-40% (in 3D mode)

4. Count Rate Performance:

•
NECR (Noise Equivalent Count Rate) curve
•
Peak NECR → determines the optimal activity range
•
At high activity → dead time and random coincidences increase → NECR falls
peak NECR → optimal activity Activity in phantom (relative) Count rate (relative) true (T) scatter (S) random (R ∝ A²) NECR = T² / (T + S + R) At high activity dead time and random coincidences increase → NECR falls. Scatter fraction in 3D mode typically 25-40% (here S/(T+S) = 35%). With the NEMA NU 2 phantom measured at annual / acceptance testing. Model: non-paralysable dead time applied to all events; relative units.

Figure 27.5: PET count rate performance: true, scatter and random coincidences with the NECR curve and peak NECR (schematic).

Did this figure help you understand the topic?

5. Image Quality Phantom (IEC Body Phantom):

•
Spheres of 6 different diameters (10, 13, 17, 22, 28, 37 mm)
•
4 hot spheres (filled with F-18), 2 cold spheres (water or air)
•
Contrast recovery and background variability are assessed
•
Contrast recovery falls in small spheres → partial volume effect
BOARD TIP
▸
"When does the partial volume effect become marked in PET?"

→ When the lesion diameter is <2-3 × the spatial resolution (i.e. 10-12 mm).

▸
"What is NECR?"

→ Noise Equivalent Count Rate → a performance measure combining true, scatter and random coincidences.

▸
"What does a streak artefact on the PET sinogram indicate?"

→ A faulty detector block.

A section through the centre of a uniform sphere, blurred by the system FWHM, is shown side by side for a hot (4:1) and a cold (0) lesion; on the right the profiles are compared with the true values. The second step shows the recovery coefficient (maximum and mean) against lesion diameter / FWHM and where the chosen lesion lies.

Continuous stream · no seeking

Key point: when the lesion is smaller than 2-3 × FWHM a hot lesion is underestimated (spill-out) and a cold lesion overestimated (spill-in); the loss is described by the recovery coefficient and can be corrected.

Source: book (PVE < 2-3 × FWHM, spill-out / spill-in, RC = measured/true, corrected = measured/RC). Calculation: convolution of a uniform sphere with a 3D Gaussian (analytic formula; σ = FWHM/2.355); hot lesion 4:1, cold 0:1; mean RC over the sphere volume. No noise or voxel size effects.

How to use: ↑ ↓ or the buttons below change the lesion diameter; the second row picks the resolution (FWHM); ← → change steps.

Speed
Test yourself:Chapter 9 · question 8
Did this animation help you understand the topic?

Figure 27.6: Hot and cold spheres in the IEC body phantom and contrast recovery by sphere diameter; partial volume effect in small spheres.

PET/CT – CT Component QC

•
The same CT QC tests as for gamma camera SPECT/CT are applied
•
Accuracy of CT-based attenuation correction: accuracy of HU → µ conversion with known materials (water, bone-equivalent)
•
PET-CT co-registration: ≤5 mm error is acceptable

ACR Accreditation Requirements (PET/CT)

•
ACR (American College of Radiology) → for PET/CT accreditation:
–
Annual physicist assessment
–
Daily QC records
–
Phantom imaging (ACR PET phantom)
–
Staff training records
–
Dose calibrator calibration records

27.3 Dose Calibrator Quality Control11 questions

General Principles

•
Dose calibrator: a pressurised gas ionisation chamber that measures radiopharmaceutical activity
•
Accurate measurement of the patient dose → critical for patient safety and regulatory compliance
•
All QC results must be recorded

Daily Quality Control

1. Constancy Test:

•
Aim: to verify day-to-day measurement consistency
•
Method: a long-lived reference source is used → Cs-137 (T½ = 30 years) or Co-57 (T½ = 271 days)
•
The measured value is compared with the decay-corrected expected value
•
Acceptable deviation: ±5% (AAPM/ANSI recommendation); old NRC rule ±10%
•
Must be done every day before patient doses are measured
BOARD TIP
▸
"Which source is used for daily dose calibrator QC?"

→ Cs-137 (most common) or Co-57.

▸
"Why a long-lived source?"

→ Daily decay is negligible → the reference value stays stable.

▸
"Acceptable deviation?"

→ ±5%.

Tests at Installation and Annually

2. Accuracy Test:

•
Aim: to verify how close the measured activity is to the true activity
•
Method: NIST-traceable reference sources are used (at least 2 different radionuclides)
•
Typical: Co-57, Ba-133, Cs-137 (different energy ranges)
•
Acceptable deviation: ±5% (AAPM recommendation; old NRC: ±10%)
•
Performed at installation + annually

3. Linearity Test:

•
Aim: to verify accurate measurement over a wide activity range
•
Method: decaying-source method (decay method) → high-activity Tc-99m source, serial measurements (over several half-lives)
•
Alternative: lead sleeve method → activity is attenuated with lead sleeves of different thicknesses
•
Activity range: from the highest clinical dose → to the lowest clinical dose
•
Acceptable deviation: ±10% (over the whole range)
•
Performed at installation and, according to EANM, every 6 months or annually
A Daily constancy (Cs-137) 0 10 20 30 −6 −4 −2 0 2 4 6 tolerance ±5% action ±3% trend → investigate before action level Day Deviation from expected (%) B Linearity: decaying Tc-99m source 0 12 24 36 48 60 0.01 0.1 1 10 100 Time (hours) Activity (GBq, log) line: expected (T½ 6.02 hours) dots: measured; acceptance ±10% EANM: action 3%, tolerance 5% (AAPM ±5%); linearity at installation and every 6 months or annually. Measurements are representative.

Figure 27.7: Dose calibrator quality control: daily constancy monitoring with Cs-137 (action ±3%, tolerance ±5%) and linearity test with a decaying Tc-99m source (±10%).

Did this figure help you understand the topic?

4. Geometry Dependence Test:

•
Aim: to assess measurement accuracy with different volumes and container geometries
•
Method: the same activity is measured in different volumes (1 mL, 5 mL, 10 mL, 20 mL syringe; vial)
•
Geometry effect: the measurement may change when source geometry changes → the calibration factor should be adjusted
•
Performed at installation
•
Accuracy, linearity and geometry tests are also repeated after a major repair or relocation of the device

EANM Notes on the Dose Calibrator (Activity Meter):

•
Daily constancy: background (without a source, at the setting of the most frequently used nuclide) and response with a long-lived reference source are measured
•
The typical action level is 3% and the tolerance limit 5%
•
Reference source: should be sealed, of known activity, with a half-life >5 years and high radionuclidic purity; e.g. Cs-137 (30.2 years)
•
System linearity is verified every 6 months or annually
•
Well-type counters: used for blood and urine samples ranging from a few kBq down to 10-100 Bq; daily quality checks are similar to those of the activity meter
•
The Mo-99 breakthrough test is not a dose calibrator test but a check of the radionuclidic purity of the eluate; it is done with the first eluate of a new generator and repeated if the generator is to be used >14 days after the first elution
•
EANM (European Pharmacopoeia): the Mo-99 fraction must not exceed 0.1% (US NRC limit 0.15 µCi/mCi ≈ 0.015%)

Dose Calibrator QC Summary Table:

TestFrequencySourceAcceptance Criterion
ConstancyDailyCs-137 or Co-57±5%
AccuracyInstallation + AnnualNIST-traceable (≥2 nuclides)±5%
LinearityInstallation + every 6 months or annuallyTc-99m (decaying source)±10%
GeometryInstallationSame activity, different volumesVariability recorded

Probes and Radiation Protection Instruments (EANM)

•
Gamma probes (radioguided surgery, SLNB): background and response constancy are checked daily with a ~200 kBq Co-57 reference source
•
A safety inspection of the probe is usually done by the manufacturer every 6 years; for a probe used during surgery, the cable and internal circuit voltage are checked before each use
•
Fixed probes used to measure dose rate at release or to quantify activity are calibrated annually with the radionuclide used in therapy
•
Dose rate meters and electronic personal dosimeters are tested with a standard source every 6 months; the sensitivity of the GM detector is checked annually

27.4 Radiopharmaceutical Quality Control (TLC, Purity Tests)13 questions

Quality Control Parameters

Three main purity parameters are assessed in radiopharmaceutical quality control:

1. Radionuclidic Purity:

•
Definition: radionuclidic purity indicates what fraction of the total radioactivity belongs to the desired radionuclide.
•
Contaminant radionuclides: unwanted radionuclides formed during production
•
Measurement method: gamma spectrometry (multichannel analyser – MCA)
–
Additional peaks outside the photopeaks of the desired radionuclide → contaminant
•
Examples:
–
Mo-99 contamination (in the Tc-99m generator): Mo-99/Tc-99m ratio → ≤0.15 µCi Mo-99 / mCi Tc-99m (NRC limit) = ≤0.15 kBq Mo-99 / MBq Tc-99m
–
Mo-99 breakthrough → deterioration of the generator column
•
Mo-99 contamination test: measurement inside a lead container (pig) → 6 mm lead absorbs Tc-99m, Mo-99 (740 keV, 780 keV) passes through
•
I-124 contamination in I-123: I-124 → high-energy gamma → degrades image quality + increases patient dose
BOARD TIP
▸
"How is the Mo-99 breakthrough test performed?"

→ The Tc-99m eluate is placed in a lead container (6 mm Pb) → Tc-99m (140 keV) is absorbed, Mo-99 (740-780 keV) passes through → measured in the dose calibrator.

▸
"NRC limit?"

→ ≤0.15 µCi Mo-99 / mCi Tc-99m.

▸
"When does Mo-99 contamination increase?"

→ As the generator ages or with excessive elution.

Dose calibrator (ionisation chamber) lead container (6 mm Pb) eluate Tc-99m 140 keV → absorbed in lead Mo-99 740 / 780 keV → passes through lead → measured Mo-99 breakthrough limits NRC: ≤0.15 µCi Mo-99 / mCi Tc-99m (= ≤0.15 kBq/MBq) European Pharmacopoeia (EANM): Mo-99 fraction ≤0.1% Done on the first eluate of a new generator; repeated if used >14 days after first elution (EANM). Not a dose calibrator test but a radionuclidic purity check of the eluate.

Figure 27.8: Mo-99 breakthrough test: a 6 mm lead container absorbs Tc-99m photons, and the high-energy photons of Mo-99 are measured (schematic).

Did this figure help you understand the topic?

2. Radiochemical Purity (RCP):

•
Definition: radiochemical purity expresses what fraction of the radioactivity is bound to the desired chemical form.
•
Radiochemical impurities:
•
Free pertechnetate (TcO₄⁻): unlabelled Tc-99m → taken up by the thyroid, stomach, salivary glands
–
Hydrolysed/reduced Tc-99m (TcO₂ – colloid): taken up by the liver, spleen, bone marrow
•
Free I-131/I-123: unlabelled iodine → thyroid uptake
•
Measurement method: thin-layer chromatography (TLC)
•
Stationary phase: ITLC-SG (silica gel) or ITLC-SA (silicic acid) strips
•
Mobile phase: acetone, saline, MEK (methyl ethyl ketone), etc.
•
Distribution of radioactivity: the strip is cut → the activity of each piece is measured

TLC Systems (Tc-99m-Labelled Radiopharmaceuticals)

System 1: ITLC-SG + Acetone

•
Free TcO₄⁻ → migrates to the front (solvent front) (Rf = 1.0)
•
Labelled compound + TcO₂ → remain at the origin (Rf = 0)
•
This system → determines the percentage of free pertechnetate

System 2: ITLC-SG + Saline (0.9% NaCl)

•
Free TcO₄⁻ + labelled compound → migrate to the front (Rf = 1.0)
•
TcO₂ (colloid) → remains at the origin (Rf = 0)
•
This system → determines the percentage of hydrolysed Tc (colloid)

RCP Calculation:

RCP (%) = 100 − (%Free TcO₄⁻ + %TcO₂)

•
Acceptable RCP: ≥90% for most Tc-99m kits (≥95% for FDG and Ga-68)
•
If RCP is low → the radiopharmaceutical must not be used
BOARD TIP
▸
"How is free pertechnetate detected in Tc-99m MDP?"

→ ITLC-SG + acetone → free TcO₄⁻ migrates to the front, the labelled compound remains at the origin.

▸
"How is colloid (TcO₂) detected?"

→ ITLC-SG + saline → TcO₂ remains at the origin, the others migrate to the front.

▸
"Where is free pertechnetate taken up?"

→ Thyroid, stomach, salivary glands.

▸
"Where is colloid taken up?"

→ Liver, spleen, bone marrow.

An ITLC-SG strip is developed first in acetone, then in saline: as the solvent rises, free pertechnetate (and in saline the Tc complex) moves to the front while the rest stays at the origin; the strip is cut and the halves counted. In the last step radiochemical purity is calculated from both results and compared with the 90% limit; three preparation scenarios can be chosen.

Continuous stream · no seeking

Key point: acetone measures free pertechnetate (moves to the front), saline measures colloidal Tc (stays at the origin); RCP = 100 − free TcO₄⁻ − colloidal Tc, and for most kits it must be at least 90%.

Source: book (ITLC-SG + acetone: TcO₄⁻ Rf 1, complex and colloid Rf 0; ITLC-SG + saline or 85% methanol: TcO₄⁻ and complex Rf 1, colloid Rf 0; RCP = 100 − free − colloid; limit ≥90%; example 4% / 2% → 94%). Percentages of the other two scenarios illustrative. Lipophilic complexes (e.g. MIBI, HMPAO) need different solvent systems.

How to use: a single click on the drawing pauses and resumes; ↑ ↓ or the buttons below change the preparation scenario; ← → change steps.

Speed
Test yourself:Chapter 27 · question 9Chapter 27 · question 10
Did this animation help you understand the topic?

Figure 27.9: Determination of free pertechnetate and hydrolysed Tc (TcO₂) in Tc-99m radiopharmaceuticals with two ITLC-SG systems, and RCP calculation (schematic).

Radiochemical Purity – Other Radiopharmaceuticals

FDG (F-18 Fluorodeoxyglucose):

•
Analysis by HPLC (High Performance Liquid Chromatography)
•
Impurities: free F-18 fluoride, chlorodeoxyglucose, acetylated FDG
•
RCP: ≥95%
•
Chemical purity: residual Kryptofix 2.2.2 (phase transfer catalyst) → ≤50 µg/mL (toxic)
•
pH: 4.5-8.5
•
Radionuclidic purity: F-18 → ≥99.5%

Ga-68 DOTATATE:

•
Analysis by TLC or HPLC
•
Free Ga-68 → impurity
•
RCP: ≥95%
•
Check for Ge-68 contamination (from the generator)

3. Chemical Purity:

•
Definition: chemical purity assesses the amount of non-radioactive chemical impurities in the preparation.
•
Examples:
•
Aluminium (Al³⁺): leakage from the alumina (Al₂O₃) column of the Mo-99/Tc-99m generator
•
Limit: ≤10 µg Al/mL eluate
•
Test: colorimetric test (aurintricarboxylic acid / aluminon test)
–
Excess Al³⁺ → flocculation (large particles) in Tc-99m sulphur colloid preparation → risk of pulmonary embolisation
•
Kryptofix 2.2.2: phase transfer catalyst used in FDG synthesis → neurotoxic
•
Limit: ≤50 µg/mL
•
Test: TLC spot test (iodoplatinate)
BOARD TIP
▸
"When is aluminium contamination in the Mo-99/Tc-99m generator a problem?"

→ When preparing Tc-99m sulphur colloid → Al³⁺ causes the colloid to flocculate → large particles form → risk of embolisation in pulmonary capillaries.

▸
"Al³⁺ limit?"

→ ≤10 µg/mL.

▸
"Test method?"

→ Colorimetric test (aurintricarboxylic acid).

Other Quality Control Parameters

4. Radionuclide Identity:

•
Verification by half-life measurement
•
Tc-99m: serial measurements confirm T½ = 6.02 hours
•
Acceptable deviation: ±10%

5. Sterility and Apyrogenicity:

•
Sterility test: membrane filtration or direct inoculation → 14 days of incubation
–
The result comes retrospectively → after the product has been used
–
Sterility is ensured by aseptic production conditions
•
Bacterial endotoxin test (BET): LAL (Limulus Amebocyte Lysate) test
–
Limit: ≤175 EU/V (V = maximum volume) or ≤14 EU/V (intrathecal products)
–
The result can be obtained before use (rapid test)

6. Particle Size (Particulate Radiopharmaceuticals):

•
Tc-99m MAA: particle size 10-90 µm (USP; European Pharmacopoeia 10-100 µm) (>90%), no particles >150 µm
–
Very large particles → risk of pulmonary embolism
–
Very small particles → not trapped in capillaries → inadequate image
•
Number of particles: 200,000-700,000 (adult dose)
•
Tc-99m sulphur colloid: particle size 0.1-1 µm (unfiltered)
•
Filtered: passed through a 0.1-0.22 µm filter → <0.22 µm
•
For the sentinel lymph node: filtered (0.22 µm filter) → smaller particles → better lymphatic drainage
BOARD TIP
▸
"Particle size of Tc-99m MAA?"

→ 10-90 µm.

▸
"Number of particles?"

→ 200,000-700,000.

▸
"What is done with the number of MAA particles in pulmonary hypertension or right-to-left shunt?"

→ Reduced (down to 100,000) → to reduce the risk of pulmonary and paradoxical embolism.

▸
"In children?"

→ 10,000-50,000 particles are sufficient.

Radiopharmaceutical QC Summary Table:

ParameterTest MethodAcceptance Criterion
Radionuclidic purityGamma spectrometry (MCA)Mo-99: ≤0.15 µCi/mCi Tc-99m
Radiochemical purityTLC (ITLC-SG)≥90% (depending on kit)
Chemical purity (Al³⁺)Colorimetric (aurin)≤10 µg/mL
Chemical purity (Kryptofix)TLC spot test≤50 µg/mL
pHpH paper / pH meter4.5-8.5 (FDG)
SterilityMembrane filtrationNo growth (14 days)
EndotoxinLAL test≤175 EU/V
Particle size (MAA)Haemocytometer / microscope10-90 µm
Radionuclide identityHalf-life measurement±10%

27.5 Licensing and Regulation (TAEK, IAEA, NRC)3 questions

International Regulatory Bodies

1. IAEA (International Atomic Energy Agency):

•
Sets international radiation safety standards
•
BSS (Basic Safety Standards): basic safety standards → reference for all member states
•
IAEA Safety Series: safety guides, reports, technical documents
•
Principles of radiation protection:
•
Justification: every radiation practice must produce a net benefit
•
Optimisation (ALARA): doses should be kept as low as reasonably achievable
•
Dose limitation: individual dose limits must not be exceeded
•
Nuclear medicine-specific guides: radiopharmaceutical production, quality assurance, patient dosimetry

2. ICRP (International Commission on Radiological Protection):

•
Publishes radiation protection recommendations → not legally binding but adopted by most countries
•
ICRP Publication 103 (2007): current dose limits
•
Occupational dose limits:
•
Effective dose: 20 mSv/year (averaged over 5 years), ≤50 mSv in a single year
•
Lens of the eye: 20 mSv/year (updated by ICRP 118, previously 150 mSv/year)
•
Skin/extremities: 500 mSv/year
•
Public dose limits:
•
Effective dose: 1 mSv/year
•
Lens of the eye: 15 mSv/year
•
Skin: 50 mSv/year
•
Pregnant radiation worker: ≤1 mSv to the fetus (over the pregnancy) or ≤0.5 mSv/month
•
Tissue weighting factors (wT): gonads 0.08, bone marrow 0.12, lung 0.12, breast 0.12, colon 0.12, stomach 0.12, thyroid 0.04, liver 0.04, oesophagus 0.04, bladder 0.04, skin 0.01, bone surface 0.01, brain 0.01, salivary glands 0.01, remainder 0.12
BOARD TIP
▸
"Annual occupational effective dose limit?"

→ 20 mSv/year (averaged over 5 years), ≤50 mSv in a single year.

▸
"Public dose limit?"

→ 1 mSv/year.

▸
"Fetal dose in a pregnant worker?"

→ ≤1 mSv (whole pregnancy).

▸
"Lens of the eye dose limit (ICRP 118)?"

→ 20 mSv/year (the old limit was 150 mSv/year → an important change!).

3. NRC (Nuclear Regulatory Commission – USA):

•
Regulates the use of radioactive material in the USA
•
10 CFR Part 20: radiation protection standards
•
Occupational dose limits (NRC):
•
TEDE (Total Effective Dose Equivalent): 5 rem/year (50 mSv/year)
•
Lens of the eye: 15 rem/year (150 mSv/year) (not yet updated to ICRP 118)
•
Skin/extremities: 50 rem/year (500 mSv/year)
•
Pregnant worker: 0.5 rem (5 mSv) to the fetus over the pregnancy
•
Public dose limit: 100 mrem/year (1 mSv/year)
•
10 CFR Part 35: medical use → byproduct material
•
Licensing categories:
•
35.600: remote afterloaders, teletherapy, gamma stereotactic units
•
35.100: uptake, dilution and excretion studies (not requiring a written directive)
•
35.200: imaging and localisation
•
35.300: unsealed source therapies requiring a written directive (I-131, Lu-177, Ra-223)
•
35.400: manual brachytherapy
•
35.1000: other medical uses (Y-90 microspheres, etc.)
•
Authorized User (AU): a physician authorised to use radioactive material
–
Board certified (ABR, ABNM) or an alternative training pathway
•
Misadministration / Medical Event:
•
Definition: wrong radiopharmaceutical, wrong patient, wrong dose (>20% deviation), wrong route of administration
•
Notification: telephone notification to the NRC within 1 calendar day + written report within 15 days
–
The patient and referring physician must be informed
BOARD TIP
▸
"Definition of a medical event (misadministration)?"

→ Wrong patient, wrong radiopharmaceutical, wrong route of administration, or >20% deviation from the prescribed dose + organ dose >50 rem or effective dose >5 rem.

▸
"Time limit for notifying the NRC?"

→ 1 calendar day (telephone) + 15 days (written).

▸
"NRC occupational dose limit?"

→ 5 rem/year (50 mSv/year) → different from ICRP!

Regulatory Bodies in Türkiye

TAEK (Turkish Atomic Energy Authority) / NDK (Nuclear Regulatory Authority):

•
Radiation safety and nuclear regulation in Türkiye
•
In 2018 (Decree-Law No. 702) the NDK was established → took over the regulatory duties of TAEK
•
Licensing: licence to use radioactive material, facility licence
•
Radiation safety regulations → consistent with ICRP and IAEA standards
•
Dose limits: in line with ICRP recommendations
•
Radiation Safety Officer (RGU): mandatory in every nuclear medicine centre
•
Personal dosimetry: TLD or OSL dosimeter → monthly/quarterly readout

ALARA Principle

•
As Low As Reasonably Achievable → doses as low as reasonably achievable
•
Three basic principles:
•
Time: minimise time spent near the radiation source
•
Distance: move away from the source → inverse square law (dose ∝ 1/d²)
•
Shielding: use shielding of appropriate thickness (lead, concrete)
•
ALARA practices in nuclear medicine:
–
Syringe shields
–
L-block shields (at workstations)
–
Lead glass (hot lab windows)
–
Automatic injectors (in PET → high-energy positron emitters)
–
Minimising contact time with the patient

How many photons from a source reach a worker depends on distance, time and lead shielding; the shielding order and bremsstrahlung for a beta source are shown.

Continuous stream · no seeking

Key point: dose rate falls with the square of distance, dose rises in proportion to time, and each HVL of lead halves the photons passing; a beta source is shielded first with low-Z material.

Source: book (Γ Tc-99m 0.78, I-131 2.17, F-18 5.7 R·cm²/mCi·h; lead HVL 0.3 / 3 / 4 mm); example 20 mCi (740 MBq) point source, body attenuation and scatter not included. Beta step: P-32 Emax 1.711 MeV (ENSDF), range NIST ESTAR, bremsstrahlung fraction Cherry, Sorenson & Phelps (Physics in Nuclear Medicine). Magnifier: Rutherford scattering; bremsstrahlung spectrum and angular distribution after Bethe–Heitler (Attix, Introduction to Radiological Physics and Radiation Dosimetry); atomic radii not to scale.

How to use: press and drag the worker (release and it moves back and forth on its own); hold ← → to change the distance smoothly; one click on the drawing pauses and resumes, double-click enlarges.

Speed
Test yourself:Chapter 10 · question 15Chapter 10 · question 7
Did this animation help you understand the topic?

Figure 27.10: The three ALARA principles: dose increasing linearly with time, the inverse square law, and shielding with the half-value layer.

Radiation Areas and Signage

•
Restricted area: an area under radiation control → authorised staff only
•
Unrestricted area: open to public access → dose limit: 2 mrem/hour (0.02 mSv/hour)
•
Radiation area: at 30 cm >5 mrem/hour (0.05 mSv/hour)
•
High radiation area: at 30 cm >100 mrem/hour (1 mSv/hour)
•
Very high radiation area: >500 rad/hour (5 Gy/hour) at 1 metre
•
Signage: three-bladed radiation symbol (trefoil) → magenta (purple) or black on a yellow background

Clinical Audit and Department Management

•
IAEA QUANUM 3.0 (2021): the management, operating and safety procedures, facilities, equipment and human resources of a nuclear medicine service are audited against predetermined standards; an audit may be partial or comprehensive
•
Internal audit (self-assessment) is recommended annually and independent external audit (peer review) at least once every three years. The process should be patient oriented, systematic and evidence based, with a no-blame culture, and follows the PDCA (plan, do, check, act) cycle
•
Evidence is gathered from written documentation, SOPs, observation of practice and staff interviews. For identified risks and non-conformances an action plan with preventive or corrective actions is prepared, prioritised, assigned to a responsible person and implemented in a timely manner
•
A QUANUM audit is advisory; it is not designed for regulatory purposes and the auditors have no power of enforcement
•
In department management, performance indicators (e.g. waiting times, waiting lists) are defined and reviewed regularly; budgetary planning and review of expenditure are part of the quality management system

Structured Reporting

•
Three levels (ESR 2018): (1) a structured format with headings (clinical information, technique, findings, conclusion); (2) consistent organisation: all relevant regions are addressed in a set order for each examination; (3) standard terminology (e.g. RadLex)
•
Benefits: complete and comparable reports, less ambiguity, and reuse of the data for staging, registries and research
•
ESR 2023 update: structured reporting in its true sense is possible only with software that stores each report item as separate data; a report standardised in content and language without such a tool is a lower level. Common templates are defined in the RSNA-ESR library (radreport.org) and the IHE MRRT profile; no national templates were reported in Turkey (2023)
•
Limitations: it may slow the workflow, oversimplify complex findings and narrow attention to the items in the template; templates should therefore leave free-text fields
•
Items common to all nuclear medicine reports (SNMMI general imaging standard; EANM/SNMMI procedure guidelines): (1) Identification: patient name, date of birth, record number, type and date of examination, referring physician. (2) Clinical information: indication and the clinical question to be answered, relevant history and treatments. (3) Technique: radiopharmaceutical, administered activity (MBq), route and site of administration, time of administration and interval to imaging, any extravasation, drugs and interventions given, type of CT (low-dose or contrast-enhanced); effective dose if required by local regulations. (4) Comparison: type and date of prior studies; if none is available, this is stated. (5) Findings and factors limiting image quality or interpretation (motion, artefact, inadequate preparation). (6) Conclusion: a clear answer to the clinical question, with differential diagnosis and recommendation where needed
–
A finding needing urgent action or an unexpected significant finding (e.g. risk of pathological fracture, unexpected malignancy) is also communicated directly to the referring physician and the communication is documented. The "Report content" items in the procedure sections of this book list only the items specific to each procedure
BOARD TIP
▸
"Definition of a radiation area?"

→ >5 mrem/hour at 30 cm.

▸
"High radiation area?"

→ >100 mrem/hour at 30 cm.

▸
"Dose limit in an unrestricted area?"

→ 2 mrem/hour.

▸
"Colours of the radiation symbol?"

→ Magenta (purple) trefoil + yellow background.

27.6 Radioactive Waste Management10 questions

Classification of Radioactive Waste

1. Short-Lived Waste (T½ ≤120 days):

•
The most common type of waste in nuclear medicine
•
Tc-99m (6 hours), I-131 (8 days), Ga-67 (78 hours), In-111 (67 hours), F-18 (110 min)
•
Decay-in-storage (DIS): disposal by decay
–
Waste is stored until its radioactivity falls to background level
–
Usually 10 half-lives are allowed → activity falls to ~1/1000
•
Tc-99m: 10 × 6 hours = 60 hours (~2.5 days)
•
I-131: 10 × 8 days = 80 days
•
F-18: 10 × 110 min = ~18 hours
•
After DIS: a radiation measurement is made → if at background level → disposed of as normal waste
•
All radioactive labels and markings must be removed

2. Long-Lived Waste (T½ >120 days):

•
C-14 (5730 years), H-3 (12.3 years), Co-57 (271 days), Cs-137 (30 years)
•
DIS cannot be applied → sent to a licensed waste disposal facility
•
Special packaging and transport rules apply

Tc-99m atoms decay at random; the measured stepped curve lies around the theoretical exponential; half-life marks, the 10 half-life rule and the mean life are shown.

Continuous stream · no seeking

Key point: the remaining activity halves with each half-life and falls below one thousandth after 10 half-lives; the mean life is 1.443 × T½.

Source: book; Tc-99m T½ 6.01 h (λ 0.115/h, τ 8.67 h).

How to use: one click on the atom panel pauses and resumes; move over or drag along the curve to read the fraction remaining at that time; ← → change steps.

Speed
Test yourself:Chapter 27 · question 15Chapter 27 · question 16
Did this animation help you understand the topic?

Figure 27.11: Decay-in-storage: after 10 half-lives the activity falls to about 1/1000.

3. Mixed Waste:

•
Both radioactive and chemically hazardous waste
•
Example: radioactive + organic solvent (acetone used in TLC, etc.)
•
The most difficult type of waste to dispose of → subject to both NRC and EPA regulations

Liquid Radioactive Waste

•
Discharge to the sewer: may be permitted under NRC rules
•
Annual limit: 1 Ci (37 GBq) in total (all radionuclides)
•
Concentration: below the limits in 10 CFR Part 20 Appendix B
–
Dilution with plenty of water is required
•
Patient urine: after I-131 therapy → may be discharged to the sewer (patient excreta are exempt)

Gaseous Radioactive Waste

•
Xe-133 ventilation studies → exhaust system with activated charcoal filter or holding tank
•
Tc-99m DTPA aerosol → minimal gaseous waste
•
I-131 therapy rooms → ventilation with activated charcoal filters

Waste Records and Documentation

•
All radioactive waste must be recorded:
–
Type of radionuclide
–
Amount of activity
–
Date
–
Disposal method
•
If DIS: storage start date, expected disposal date, measurement results
•
Records must be kept for a minimum of 3 years (NRC rule)

Transport of Radioactive Material

•
Packaging in accordance with DOT (Department of Transportation) and IAEA rules
•
Package types:
•
Exempt package: very low activity
•
Type A package: low-medium activity → withstands normal transport conditions
•
Type B package: high activity → withstands accident conditions (fire, impact, water)
•
Transport index (TI): dose rate of the package at 1 metre (mrem/hour)
–
TI = 0 → White-I label (radiation symbol)
–
TI ≤1 (surface ≤50 mrem/hour) → Yellow-II label
–
TI ≤10 (surface ≤200 mrem/hour) → Yellow-III label
–
TI >10 → exclusive use
BOARD TIP
▸
"How many half-lives are allowed for decay-in-storage?"

→ 10 half-lives (falls to ~1/1000).

▸
"DIS time for I-131 waste?"

→ 80 days.

▸
"DIS time for Tc-99m waste?"

→ ~60 hours.

▸
"What is the transport index (TI)?"

→ Dose rate of the package at 1 metre (mrem/hour).

▸
"What does a White-I label mean?"

→ TI = 0 and surface dose rate ≤0.5 mrem/hour.

Transport index (TI) = dose rate of the package at 1 m (mrem/h) RADIOACTIVE I White-I TI = 0 surface ≤0.5 mrem/h RADIOACTIVE II Yellow-II TI ≤1 surface ≤50 mrem/h RADIOACTIVE III Yellow-III TI ≤10 surface ≤200 mrem/h Vehicle exclusive use Exclusive use TI >10 (exclusive use) The label's radiation symbol (trefoil) is black; on Yellow labels the upper half is yellow. Roman numerals with red bars.

Figure 27.12: Radioactive package labels: White-I, Yellow-II, Yellow-III and exclusive use according to the transport index (TI) and surface dose rate (schematic).

Did this figure help you understand the topic?

Contamination and Decontamination

Types of Contamination:

•
Fixed contamination: bound to the surface → cannot be detected by a wipe test
•
Removable contamination: detected by a wipe test → more hazardous (risk of spread)

Detection of Contamination:

•
Wipe (smear) test: an area of 100 cm² is wiped → measured in a well counter
•
Limit: 200 dpm/100 cm² (removable contamination) → differs in some regulations
•
Portable detector: surface survey with a GM counter or ionisation chamber

Principles of Decontamination:

•
Personnel decontamination: clothing removed first → washing with plenty of water and soap → gentle scrubbing
–
No harsh scrubbing → skin integrity is broken → radioactive material is absorbed
–
Wound contamination → irrigation with plenty of water
•
Surface decontamination: clean from the outside inwards → prevent spread of contamination
–
Mild detergent + water → repeated wiping
–
Persistent contamination → the surface covering is removed
•
Spill management:
•
Minor spill: put on gloves → cover with absorbent paper → clean from the outside inwards → confirm with a wipe test
•
Major spill: evacuate the area → inform the RSO (Radiation Safety Officer) → mark the contaminated area → professional decontamination
Radioactive spill Minor spill Major spill 1. Put on gloves 1. Evacuate the area 2. Cover with absorbent paper 2. Inform the RSO 3. Clean from outside inwards 3. Mark the contaminated area 4. Confirm with a wipe test 4. Professional decontamination Personnel decontamination: remove clothing → plenty of water + soap, gentle scrubbing (NO hard scrubbing); wound → irrigate with plenty of water. Surface: outside inwards, mild detergent; wipe limit 200 dpm/100 cm² (removable).

Figure 27.13: Management of minor and major radioactive spills and principles of personnel decontamination.

Did this figure help you understand the topic?

Key Points for the Board

Gamma Camera Quality Control

•
First daily test: energy peak check (peaking) → if the photopeak is wrong, everything is affected
•
Daily uniformity: intrinsic = without collimator + point source (5 × FOV); extrinsic = with collimator + flood source
•
Uniformity formula: IU = (Max − Min) / (Max + Min) × 100%
•
Acceptable integral uniformity: ≤3-5% (intrinsic), ≤5% (extrinsic)
•
Minimum counts: 3-5 million (daily), >30-100 million (annual high-count)
•
Weekly: spatial resolution and linearity with a bar phantom
•
COR test: every 3-6 months, acceptable error ≤0.5 pixel
•
SPECT ring artefact → non-uniformity
•
SPECT doubling → COR error
•
NaI(Tl) energy resolution: 9-10% (at 140 keV)
•
A planar non-uniformity of ~1% can grow to ~20% in SPECT → correction map: ~30 million counts at 64×64, ~120 million at 128×128
•
Co-57 sheet source (versus a Tc-99m liquid phantom): no preparation, constant thickness, no bubble/poor-mixing artefacts, low staff dose
•
Multiple window spatial registration (MWSR): superimposition of window images for multi-peak nuclides such as Ga-67/In-111; blurring when faulty

PET/CT Quality Control

•
Daily QC source: Ge-68 (T½ = 271 days, positron emitter)
•
PET spatial resolution: 4-6 mm (FWHM)
•
SUV accuracy: ±10% acceptable
•
NECR: Noise Equivalent Count Rate → determines the optimal activity range
•
Streak artefact on the sinogram → faulty detector block
•
Partial volume effect: becomes marked when lesion diameter is <2-3 × resolution
•
IEC body phantom: 6 spheres (10-37 mm) → contrast recovery assessment

Dose Calibrator Quality Control

•
Daily: constancy → Cs-137 → ±5%
•
Annual: accuracy → NIST-traceable → ±5%
•
Every 6 months or annually: linearity → decaying source → ±10%
•
At installation: geometry dependence
•
Accuracy, linearity and geometry tests are repeated after a major repair or relocation

Radiopharmaceutical Quality Control

•
Radionuclidic purity: gamma spectrometry → Mo-99 breakthrough: ≤0.15 µCi/mCi Tc-99m
•
Mo-99 test: lead container (6 mm Pb) → Tc-99m is absorbed, Mo-99 passes through
•
Radiochemical purity (RCP): TLC → ≥90% (most Tc-99m kits; FDG/Ga-68 ≥95%)
•
Free TcO₄⁻: ITLC-SG + acetone → TcO₄⁻ migrates to the front
•
Colloid (TcO₂): ITLC-SG + saline → TcO₂ remains at the origin
•
Uptake of free TcO₄⁻: thyroid, stomach, salivary glands
•
Uptake of TcO₂ (colloid): liver, spleen, bone marrow
•
Chemical purity: Al³⁺ ≤10 µg/mL (colorimetric test) → risk of flocculation in sulphur colloid
•
FDG: Kryptofix ≤50 µg/mL, RCP ≥95%, pH 4.5-8.5
•
MAA particle size: 10-90 µm, number: 200,000-700,000
•
Pulmonary HT / right-to-left shunt → number of MAA particles reduced (≤100,000)

Licensing and Regulation

•
ICRP 103 occupational dose: 20 mSv/year (5-year average), ≤50 mSv in a single year
•
NRC occupational dose: 50 mSv/year (5 rem/year) → different from ICRP!
•
Lens of the eye (ICRP 118): 20 mSv/year (previously 150 mSv/year → an important change)
•
Public dose limit: 1 mSv/year
•
Fetal dose in a pregnant worker: ICRP → ≤1 mSv; NRC → ≤5 mSv (0.5 rem)
•
Medical event: >20% deviation + organ dose >50 rem or effective dose >5 rem
•
NRC notification: 1 day by telephone + 15 days written report
•
ALARA: time, distance, shielding
•
Radiation area: at 30 cm >5 mrem/hour
•
High radiation area: at 30 cm >100 mrem/hour
•
Unrestricted area limit: 2 mrem/hour

Radioactive Waste Management

•
DIS: 10 half-lives are allowed → activity falls to ~1/1000
•
Tc-99m DIS: ~60 hours; I-131 DIS: ~80 days; F-18 DIS: ~18 hours
•
After DIS: radioactive labels must be removed → disposed of as normal waste
•
Long-lived waste (T½ >120 days): DIS cannot be applied → licensed facility
•
Mixed waste: most difficult to dispose of → subject to both NRC and EPA regulations
•
Discharge to the sewer: ≤1 Ci in total per year
•
Transport labels: White-I (TI = 0, surface ≤0.5), Yellow-II (TI ≤1, surface ≤50), Yellow-III (TI ≤10, surface ≤200)
•
Wipe test limit: 200 dpm/100 cm²
•
Decontamination: no harsh scrubbing → skin integrity is broken → absorption increases.

Additional Notes from EANM Guidelines:

•
Dose calibrator: action level 3%, tolerance limit 5%; linearity at intervals of ≥6 months; reference source T½ >5 years (Cs-137)
•
Mo-99 breakthrough: eluate purity test; first eluate, repeated after >14 days; European limit 0.1%
•
SPECT/CT alignment ≤5 mm; PET/CT alignment every 6 months; daily PET QC with a Ge-68 phantom or Lu-176 (LSO)
•
Probe: ~200 kBq Co-57 for daily constancy; EARL → quantitative harmonisation between centres

Current guidelines on this chapter's topics

The latest guidelines and consensus documents on the procedures covered in this chapter (official EANM index and primary sources, November 2026). Comparison of the text with these versions is in progress; consult the guideline itself for details.

  1. 2023ESR paper on structured reporting in radiology — update 2023 (opens in a new tab)
  2. 2022EANM guidelines for PET-CT and PET-MR routine quality control (opens in a new tab)
  3. 2022EANM guideline on quality risk management for radiopharmaceuticals (opens in a new tab)
  4. 2021QUANUM 3.0: An Updated Tool for Nuclear Medicine Audits (IAEA) (opens in a new tab)
  5. 2010Routine Quality Control Recommendations for Nuclear Medicine Instrumentation (opens in a new tab)
  6. 2010Acceptance Testing for Nuclear Medicine Instrumentation (opens in a new tab)

Finished the chapter?

This chapter has 25 questions. Solve them now to consolidate the topic.

Solve questions →
Previous chapterRadionuclide TherapyNext chapterNew Developments - Theranostics and Artificial Intelligence

You can also swipe sideways to change chapter

The first daily test is the energy peak check: with a Tc-99m point source the 140 keV photopeak is confirmed to be centred in the ±10% window. If PMT gain drifts, the peak slides out of the window; counts in the window fall, the share of scattered photons and the uniformity worsen. That is why the peak check comes before the other tests. In the drawing the gain drifts by itself between −8% and +8%.

Energy peak checkwindow 126-154 keV (±10%)100120140160180energy (keV)countsgain drift +7.4% → photopeak 150 keV
Photopeak counts inside the window-10-50510050100gain drift (%)in window (%)Peak shifted: 74% in window; adjustDashed curve: correct setting; commonest cause is PMT gain drift.

The uniformity test gives the detector an even flux: intrinsic with the collimator off and a point source at 5 × FOV, extrinsic with the collimator on and a flood source. At least 3-5 million counts are collected. Integral uniformity is calculated in the UFOV and CFOV after 9-point smoothing; intrinsic IU should be ≤3-5% (UFOV) and ≤3% (CFOV). As counts grow the Poisson noise share falls; with a PMT failure IU stays high. Pick the condition.

Flood uniformityUFOVCFOVTotal counts: 0.0 million
Integral uniformity (NEMA)IU (%) = (max − min) / (max + min) × 100UFOV: %0.0≤5%CFOV: %0.0≤3%PMT failure: local count loss (dark spot);IU stays high despite more counts9-point smoothing; at least 3-5 million counts.

The weekly test images a four-quadrant bar phantom (2.0, 2.5, 3.0, 3.5 mm). Lines should be straight and parallel; a PMT or electronics problem bends them (linearity fault). A bar spacing is resolved when the bar width exceeds roughly FWHM/1.75; with an intrinsic resolution of 3-4 mm the finest quadrant is at the limit. Pick the condition.

Bar phantom: linearity and resolution2.0 mm2.5 mm3.0 mm3.5 mmSchematic; intrinsic; counts bright, lead bars (no counts) dark.
Which quadrants are resolved?Linearity fault: lines bend around a PMT(PMT/electronics problem)2.0 mm✓2.5 mm✓3.0 mm✓3.5 mm✓FWHM 3.5 mm → FWHM/1.75 ≈ 2.0 mm

If the mechanical centre of rotation and the electronic centre of the image disagree, every projection is shifted by the same amount. A point source at the centre blurs with a small shift and becomes a ring (doughnut) with a large one; the sinusoid in the sinogram is off-centre. COR quality control with a point or line source is done every 3-6 months and after collimator change or service.

COR (centre of rotation) errorSinogram0°360°angledetector positionSinusoid shifted 4 pixels
Slice (FBP)centre enlargedRing (doughnut)large COR error; COR test every 3-6 months and after service

Step 1/2

Spill-out and spill-in

The system blurs every point to the width of its FWHM. Activity of a small hot lesion spreads outwards (spill-out) and is underestimated; activity from the surroundings spills into a small cold lesion (spill-in), which looks higher than it is. In both cases contrast falls. Make the lesion smaller: at 8 mm FWHM the centre of a 5 mm hot lesion stays far below the true value.

Hot and cold lesionhot lesion (4:1)centre 2.38 (true 4)RC_max 46%cold lesion (0:1)centre 0.54 (true 0)spill-inD = 10 mm · FWHM = 8 mm · D/FWHM = 1.3
Profile through the centrehot lesion (4:1)14cold lesion (0:1)01−20−1001020position (mm)truemeasured

Step 1/3

Acetone strip

A drop of the preparation is spotted on an ITLC-SG strip, which is placed in acetone. As the solvent rises, free pertechnetate moves with it to the front (Rf 1); the Tc complex and colloidal Tc stay at the origin (Rf 0). The strip is cut in the middle and both halves counted: the fraction at the front is free TcO₄⁻. Change the preparation.

ITLC-SG + acetoneacetoneThe strip is cut in the middle and both halves are counted.free TcO₄⁻Tc complexcolloidal Tc
Counts of the cut halvescounts in the dose calibrator%0%50%100frontorigin

Step 1/3

Distance: inverse square law

Photons spread out from the source in all directions; with distance the same number of photons covers a larger area. Dose rate is inversely proportional to the square of distance: Ḋ₁·d₁² = Ḋ₂·d₂². Doubling the distance cuts dose 4-fold, tripling it 9-fold. That is why long tongs and remote injection work.

Ẋ = Γ·A/d² = 6.2 mR/hPhotons reaching the body/s: 0.0Worker50100200d = 50 cmTc-99m20 mCi

Example: 20 mCi (740 MBq) source. Γ (R·cm²/mCi·h) and lead HVL from the book: Tc-99m 0.78 / 0.3 mm, I-131 2.17 / 3 mm, F-18 5.7 / 4 mm. Ẋ = Γ·A/d² applies to a point source; body attenuation and scatter are not included. Photons are generated in random 3D directions; hits on the body fall as 1/d².

Each half-life halves what remains: 1 T½ 50%, 2 T½ 25%, 3 T½ 12.5%, 4 T½ 6.25%, 5 T½ 3.125%; ~0.78% at 7 T½ and ~0.098% at 10 T½ (about one in a thousand). This is the source of the 10 half-life rule for decay-in-storage. On a logarithmic axis the curve is a straight line. Move along the graph to see the fraction left at any hour and how much of 30 mCi remains (7.5 mCi after 12 h).

Axis:
Fraction remaining (each dot 0.1%)Remaining: 1000 / 1000 dots0.0 T½ · 100%
100%75%50%25%012345678910T½Remaining50%25%12.5%0.0 h: 100% left · 30 mCi → 30.0 mCi

Hover over the graph or drag with your finger: the fraction left at that hour and what remains of a 30 mCi sample appear.